Plant Comparison
Cordyceps vs Rhodiola Rosea
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Cordyceps and Rhodiola Rosea: they share 7 indicated uses (arthritis / joint pain, cold & flu, fatigue / low energy, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Cordyceps | Rhodiola Rosea | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 6/10 | Comparable evidence |
| Cold & flu | 5/10 | 6/10 | Comparable evidence |
| Fatigue / low energy | 6/10 | 10/10 | Stronger for Rhodiola Rosea |
| Immune support | 5/10 | 6/10 | Comparable evidence |
| Inflammation (general) | 5/10 | 9/10 | Stronger for Rhodiola Rosea |
| Muscle soreness | 6/10 | 9/10 | Stronger for Rhodiola Rosea |
| Skin irritation | 5/10 | 6/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
A nucleoside analogue considered the marker bioactive compound, studied for anti-inflammatory, antioxidant and metabolic effects.
Immunomodulatory and antioxidant polysaccharides, a major focus of both oral and topical product development.
Additional characteristic fungal sterol and nucleoside constituents.
Characteristic phenylpropanoid glycosides largely unique to Rhodiola rosea, used as a standardisation marker for commercial extracts.
Phenylethanoid glycosides considered key adaptogenic and antioxidant constituents.
Contribute to the anti-inflammatory and antioxidant activity of the root.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally well tolerated short-term in human studies, but research is still limited (Ontawong et al., 2024; Hirsch et al., 2016). Possible side effects: stomach upset, nausea, diarrhea, headache (reported broadly for “Cordyceps” supplements; not everyone gets this) (Jędrejko, Lazur and Muszyńska, 2021). Avoid / use medical guidance if you have: autoimmune disease, you’re on immunosuppressants, you have a bleeding disorder, or you take blood thinners/antiplatelet drugs (theoretical interaction + caution used in reviews) (Jędrejko, Lazur and Muszyńska, 2021). Pregnancy/lactation: not enough safety data → best to avoid (Jędrejko, Lazur and Muszyńska, 2021). Quality matters: choose reputable brands with testing for contaminants and clear labeling (fruiting body vs mycelium; extract ratio) (Jędrejko et al., 2022).
Generally well tolerated. May cause agitation, insomnia, or vivid dreams in sensitive individuals — take in the morning. Avoid in manic episodes or severe anxiety. Theoretical interactions with MAOIs, SSRIs, and CNS stimulants. Avoid during pregnancy and breastfeeding.
External Ids
Botanical Description
Entomopathogenic fungus (not a true plant) that develops from a mycelium infecting and consuming an insect host - classically a moth caterpillar or pupa buried in the soil. In late season it produces a slender, bright orange, club-shaped fruiting body (stroma) that emerges from the ground above the mummified host, its surface minutely roughened with embedded spore-producing structures.[4]
Succulent perennial herb (Crassulaceae), 15-40 cm tall, with a thick, fleshy, branching rhizome that has a rose-like fragrance when cut - the origin of the name 'rosea'. Leaves are fleshy, greyish-green, oval to oblong. Small yellow (occasionally reddish) flowers are clustered in dense terminal heads; the species is dioecious, with separate male and female plants. Fruit follicles turn red as they ripen.[3]
Habitat
Grows on insect larvae and pupae in cool, moist forest soils and grassland across temperate and alpine East Asia; commercially, most Cordyceps militaris is now cultivated on grain or insect-based substrate rather than wild-collected.[4]
Native to arctic and mountainous regions of Europe, Asia and North America (circumpolar), growing in cold, rocky, high-altitude or high-latitude terrain - cliffs, rocky slopes and tundra - tolerating harsh, exposed conditions.[3]
Harvesting
Wild fruiting bodies are dug up carefully with the insect host attached, in autumn when they emerge; cultivated material is harvested from the growing substrate once the orange fruiting bodies mature, then dried.
Rhizome and root are dug from plants at least a few years old (traditionally 4-5 years), typically in autumn, then cleaned and dried. Wild populations grow slowly, so cultivated sources are increasingly preferred for sustainability.[3]
Traditional Uses
Rhodiola has a long tradition of use across Scandinavian, Russian and Central Asian folk medicine as a tonic for cold-climate hardiness, physical endurance and mental stamina. It is classified as a modern 'adaptogen', and clinical trials support benefits for stress-related fatigue, mood and cognitive performance.[1, 3]
Preparations
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Dosage
Drug Class Interactions
Not documented
Pairings
Not documented
Rhodiola and eleuthero (Siberian ginseng) are classic adaptogens combined in traditional and studied fixed formulas to build resistance to stress and fatigue; used together their stress-protective effects are complementary.[17, 18]
Rhodiola and schisandra are adaptogens co-formulated in clinically studied combinations for stress, fatigue and mental performance; combined use is intended to be synergistic rather than harmful.[17, 18]
References & Sources
- Lan, T., Yu, Y., Zhang, J., Li, H. et al (2021) 'Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway', Hepatology, 74(2), pp. 686-703. doi:10.1002/hep.31749 Preclinical
https://doi.org/10.1002/hep.31749 - Wei, P., Wang, K., Luo, C., Huang, Y. et al (2021) 'Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury', Journal of Neuroinflammation, 18(1), pp. 137. doi:10.1186/s12974-021-02188-x Preclinical
https://doi.org/10.1186/s12974-021-02188-x - Tan, L., Song, X., Ren, Y., Wang, M. et al (2020) 'Anti-inflammatory effects of cordycepin: A review', Phytotherapy Research. doi:10.1002/ptr.6890 Traditional / reference
https://doi.org/10.1002/ptr.6890 - Kanlayavattanakul, M. and Lourith, N (2023) 'Cordyceps militaris polysaccharides: preparation and topical product application', Fungal Biology and Biotechnology, 10(1), pp. 3. doi:10.1186/s40694-023-00150-5 Meta-analysis / review
https://doi.org/10.1186/s40694-023-00150-5 - Yang, W., Fu, C., Hu, B., Yan, Y. and Cheng, Y (2024) 'Five undescribed cyclopeptides from Cordyceps militaris', Phytochemistry, 222, pp. 114074. doi:10.1016/j.phytochem.2024.114074 Preclinical
https://doi.org/10.1016/j.phytochem.2024.114074 - Miao, M., Yu, W., Li, Y., Sun, Y. and Guo, S (2022) 'Structural elucidation and activities of Cordyceps militaris-derived polysaccharides: a review', Frontiers in Nutrition, 9, pp. 898674. doi:10.3389/fnut.2022.898674 Meta-analysis / review
https://doi.org/10.3389/fnut.2022.898674 - Jedrejko, K.J., Lazur, J. and Muszynska, B (2021) 'Cordyceps militaris: an overview of its chemical constituents in relation to biological activity', Foods, 10(11), pp. 2634. doi:10.3390/foods10112634 Meta-analysis / review
https://doi.org/10.3390/foods10112634 - Malucka, L.U., Uhrinova, A. and Lysinova, P (2022) 'Medicinal mushrooms Ophiocordyceps sinensis and Cordyceps militaris', Ceska a Slovenska Farmacie, 71(6), pp. 259-265. doi:10.5817/csf2022-5-259 Meta-analysis / review
https://doi.org/10.5817/csf2022-5-259 - Sun, J., Jin, M., Zhou, W., Diao, S., Zhou, Y., Li, S., Wang, X., Pan, S., Jin, X. and Li, G (2017) 'A new ribonucleotide from Cordyceps militaris', Natural Product Research, 31(21), pp. 2537-2543. doi:10.1080/14786419.2017.1323210 Preclinical
https://doi.org/10.1080/14786419.2017.1323210 - Choi, E., Oh, J. and Sung, G.H (2020) 'Antithrombotic and antiplatelet effects of Cordyceps militaris', Mycobiology, 48(3), pp. 228-232. doi:10.1080/12298093.2020.1763115 Preclinical
https://doi.org/10.1080/12298093.2020.1763115 - Zhang, J., Wen, C., Duan, Y., Zhang, H. and Ma, H (2019) 'Advance in Cordyceps militaris (Linn) Link polysaccharides: isolation, structure, and bioactivities: a review', International Journal of Biological Macromolecules, 132, pp. 906-914. doi:10.1016/j.ijbiomac.2019.04.020 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2019.04.020 - Chiu, C.P., Liu, S.C., Tang, C.H., Chan, Y., El-Shazly, M., Lee, C.L., Du, Y.C., Wu, T.Y., Chang, F.R. and Wu, Y.C (2016) 'Anti-inflammatory cerebrosides from cultivated Cordyceps militaris', Journal of Agricultural and Food Chemistry, 64(7), pp. 1540-1548. doi:10.1021/acs.jafc.5b05931 Preclinical
https://doi.org/10.1021/acs.jafc.5b05931 - Chamyuang, S., Owatworakit, A. and Honda, Y (2019) 'New insights into cordycepin production in Cordyceps militaris and applications', Annals of Translational Medicine, 7(Suppl 3), pp. S78. doi:10.21037/atm.2019.04.12 Meta-analysis / review
https://doi.org/10.21037/atm.2019.04.12 - Cui, J.D (2015) 'Biotechnological production and applications of Cordyceps militaris, a valued traditional Chinese medicine', Critical Reviews in Biotechnology, 35(4), pp. 475-484. doi:10.3109/07388551.2014.900604 Meta-analysis / review
https://doi.org/10.3109/07388551.2014.900604 - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Zhu, J.S., Halpern, G.M. and Jones, K (1998) 'The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis', 4(3), pp. 289--303. doi:10.1089/acm.1998.4.429 Randomized trial
https://doi.org/10.1089/acm.1998.4.429 - Hirsch, K.R., Smith-Ryan, A.E., Roelofs, E.J., Trexler, E.T. and Mock, M.G (2017) 'Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation', 14(1), pp. 42--53. doi:10.1080/19390211.2016.1203386 Randomized trial
https://doi.org/10.1080/19390211.2016.1203386 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Chemistry World (Royal Society of Chemistry) 'Poisons leave no mushroom for error'. Available at: https://www.chemistryworld.com/opinion/poisons-leave-no-mushroom-for-error/4011376.article Traditional / reference
https://www.chemistryworld.com/opinion/poisons-leave-no-mushroom-for-error/4011376.article - Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043 - Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265
- Ivanova Stojcheva, E. and Quintela, J.C (2022) 'The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - Encouraging Clinical Evidence', Molecules, 27(12), pp. 3902. doi:10.3390/molecules27123902 Meta-analysis / review
https://doi.org/10.3390/molecules27123902 - Pu, W.L., Zhang, M.Y., Bai, R.Y., Sun, L.K. and others (2019) 'Anti-inflammatory effects of Rhodiola rosea L.: A review', Biomedicine & Pharmacotherapy, 121, pp. 109552. doi:10.1016/j.biopha.2019.109552 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2019.109552 - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', Phytomedicine, 17(7), pp. 481-493. doi:10.1016/j.phymed.2010.02.002 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.02.002 - Tinsley, G.M., Jagim, A.R., Potter, G.D.M., Garner, D. and Galpin, A.J (2023) 'Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature', The British Journal of Nutrition, 131(3), pp. 461-473. doi:10.1017/S0007114523001988 Meta-analysis / review
https://doi.org/10.1017/S0007114523001988 - Cropley, M., Banks, A.P. and Boyle, J (2015) 'The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms', Phytotherapy Research, 29(12), pp. 1934-1939. doi:10.1002/ptr.5486 Randomized trial
https://doi.org/10.1002/ptr.5486 - Amsterdam, J.D. and Panossian, A.G (2016) 'Rhodiola rosea L. as a putative botanical antidepressant', Phytomedicine, 23(7), pp. 770-783. doi:10.1016/j.phymed.2016.02.009 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2016.02.009 - Olsson, E.M., von Scheele, B. and Panossian, A.G (2009) 'A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue', Planta Medica, 75(2), pp. 105-112. doi:10.1055/s-0028-1088346 Randomized trial
https://doi.org/10.1055/s-0028-1088346 - Ishaque, S., Shamseer, L., Bukutu, C. and Vohra, S (2012) 'Rhodiola rosea for physical and mental fatigue: a systematic review', BMC Complementary and Alternative Medicine, 12, pp. 70. doi:10.1186/1472-6882-12-70 Meta-analysis / review
https://doi.org/10.1186/1472-6882-12-70 - Borgonetti, V., Governa, P., Biagi, M., Dalia, P. and Corsi, L (2019) 'Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model', Phytomedicine, 68, pp. 153143. doi:10.1016/j.phymed.2019.153143 Preclinical
https://doi.org/10.1016/j.phymed.2019.153143 - Coors, A., Brosch, M., Kahl, E., Khalil, R. and others (2019) 'Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating', Journal of Ethnopharmacology, 235, pp. 320-328. doi:10.1016/j.jep.2019.02.031 Preclinical
https://doi.org/10.1016/j.jep.2019.02.031 - Darbinyan, V. et al (2000) 'Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5', 7(5), pp. 365--371. Randomized trial
https://scholar.google.com/scholar?q=Rhodiola%20rosea%20in%20stress%20induced%20fatigue%20%E2%80%94%20a%20double%20blind%20cross-over%20study%20of%20a%20standardized%20extract%20SHR-5 - Kelly, G.S (2001) 'Rhodiola rosea: a possible plant adaptogen', 6(3), pp. 293--302. Traditional / reference
https://scholar.google.com/scholar?q=Rhodiola%20rosea%3A%20a%20possible%20plant%20adaptogen - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', 17(7), pp. 481--493. doi:10.1016/j.phymed.2010.02.002 Randomized trial
https://doi.org/10.1016/j.phymed.2010.02.002 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Maniscalco, I., Toffol, E., Giupponi, G. and Conca, A (2014) 'The interaction of Rhodiola rosea and antidepressants. A case report', Neuropsychiatrie, 29(1), pp. 36-38. doi:10.1007/s40211-014-0124-8 Clinical study
https://doi.org/10.1007/s40211-014-0124-8 - van Diermen, D., Marston, A., Bravo, J., Reist, M., Carrupt, P.A. and Hostettmann, K (2009) 'Monoamine oxidase inhibition by Rhodiola rosea L. roots', Journal of Ethnopharmacology, 122(2), pp. 397-401. doi:10.1016/j.jep.2009.01.007 Preclinical
https://doi.org/10.1016/j.jep.2009.01.007 - Panossian, A.G (2013) 'Adaptogens in mental and behavioral disorders', Psychiatric Clinics of North America, 36(1), pp. 49-64. doi:10.1016/j.psc.2012.12.005 Meta-analysis / review
https://doi.org/10.1016/j.psc.2012.12.005 - Karosanidze, I., Kiladze, U., Kirtadze, N., Giorgadze, M. and Panossian, A (2022) 'Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial', Pharmaceuticals, 15(3), pp. 345. doi:10.3390/ph15030345 Randomized trial
https://doi.org/10.3390/ph15030345
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.